DRD2 and psychotic disorder: It has been accepted that subcortical hyperdopaminergia is implicated in psychosis, confirmed further by the neuropharmacological action of antipsychotic drugs currently available; all licensed pharmacological treatments of psychosis (antipsychotics) require interactions with the dopamine D2 receptor [50].